Enhancing preclinical drug discovery with artificial intelligence.
Researchers
Journal
Modalities
Models
Abstract
Artificial intelligence (AI) is becoming an integral part of drug discovery. It has the potential to deliver across the drug discovery and development value chain, starting from target identification and reaching through clinical development. In this review, we provide an overview of current AI technologies and offers a glimpse of how AI is reimagining preclinical drug discovery by highlighting examples where AI has made a real impact. Considering the excitement and hyperbole surrounding AI in drug discovery, we present a realistic view by discussing both opportunities and challenges in adopting AI in drug discovery.Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.